World's Best Scientists 2026 revealed!
Håkan Mellstedt

Håkan Mellstedt

D-Index & Metrics

Discipline name D-Index World Ranking National Ranking Publications Citations
Immunology 82 1523 28 494 21562
Medicine 83 15736 287 504 22337

Håkan Mellstedt publications per year

The chart shows the history of publications by Håkan Mellstedt between 1973 and 2023, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Håkan Mellstedt published across 51 years, from 1973 to 2023, averaging 10 papers a year. Output peaked at 51 publications in 2009. 4 of the 511 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 1973 to 2023. Vertical axis: number of publications, 0 to 51. Peak 51 publications in 2009. 1973: 1 publication 1974: 4 publications 1975: 4 publications 1976: 4 publications 1977: 3 publications 1978: 4 publications 1979: 4 publications 1980: 7 publications 1981: 5 publications 1982: 11 publications 1983: 8 publications 1984: 7 publications 1985: 11 publications 1986: 3 publications 1987: 10 publications 1988: 11 publications 1989: 22 publications 1990: 15 publications 1991: 20 publications 1992: 8 publications 1993: 10 publications 1994: 10 publications 1995: 15 publications 1996: 11 publications 1997: 10 publications 1998: 7 publications 1999: 11 publications 2000: 8 publications 2001: 8 publications 2002: 9 publications 2003: 11 publications 2004: 21 publications 2005: 11 publications 2006: 13 publications 2007: 18 publications 2008: 14 publications 2009: 51 publications 2010: 12 publications 2011: 10 publications 2012: 12 publications 2013: 16 publications 2014: 14 publications 2015: 10 publications 2016: 5 publications 2017: 11 publications 2018: 7 publications 2019: 3 publications 2020: 2 publications 2021: 5 publications 2022: 1 publication 2023: 3 publications
1973 2023

511 publications in total across all disciplines

View publications per year as a table
Håkan Mellstedt: publications per year, 1973 to 2023
Year Publications
1973 1
1974 4
1975 4
1976 4
1977 3
1978 4
1979 4
1980 7
1981 5
1982 11
1983 8
1984 7
1985 11
1986 3
1987 10
1988 11
1989 22
1990 15
1991 20
1992 8
1993 10
1994 10
1995 15
1996 11
1997 10
1998 7
1999 11
2000 8
2001 8
2002 9
2003 11
2004 21
2005 11
2006 13
2007 18
2008 14
2009 51
2010 12
2011 10
2012 12
2013 16
2014 14
2015 10
2016 5
2017 11
2018 7
2019 3
2020 2
2021 5
2022 1
2023 3
Total 511
Download as CSV

Håkan Mellstedt publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Håkan Mellstedt sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 492–501 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 494 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30 494
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Håkan Mellstedt D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Håkan Mellstedt sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 82–83 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 82 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125 82
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Håkan Mellstedt is affiliated with the Karolinska Institute in Sweden and has contributed to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans several subfields including Oncology, Molecular Biology, Immunology, Genetics, and Hematology.

The scientist's main research topics cover Chronic Lymphocytic Leukemia Research, Phagocytosis and Immune Regulation, Chronic Myeloid Leukemia Treatments, Lung Cancer Research Studies, PI3K/AKT/mTOR signaling in cancer, Wnt/β-catenin signaling in development and cancer, and Acute Lymphoblastic Leukemia research.

Recent publications include:

  • Polymorphisms within methotrexate pathway genes: Relationship between plasma methotrexate levels, toxicity experienced and outcome in pediatric acute lymphoblastic leukemia, 2020, PubMed
  • Predicting ROR1/BCL2 combination targeted therapy of small cell carcinoma of the lung, 2021, Cell Death and Disease
  • A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells, 2022, Pharmaceutics
  • A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib-resistant ROR1+ CLL cells, 2021, eJHaem
  • Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules, 2021, Handbook of experimental pharmacology

Frequent publication venues for the scientist include:

  • Pharmaceutics
  • eJHaem
  • PubMed
  • Cell Death and Disease
  • Journal of Hematology

Regular co-author collaborations feature the following researchers:

  • Mohammad Hojjat-Farsangi
  • Johan Schultz
  • Anders Österborg
  • Thomas Olin
  • Marzia Palma

Best Publications

  • Therapeutic vaccines for cancer: an overview of clinical trials

    Ignacio Melero;Gustav Gaudernack;Winald Gerritsen;Christoph Huber

  • Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).

    Jeanette Lundin;Eva Kimby;Magnus Björkholm;Per-Anders Broliden

  • Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.

    A. Österborg;M. J. S. Dyer;D. Bunjes;G. A. Pangalis

  • Epithelial cell adhesion molecule expression (CD326) in cancer: A short review

    Carlo Patriarca;Roberto Maria Macchi;Anja K. Marschner;Hakan Mellstedt

  • Decreased Expression of the Signal-transducing ζ Chains in Tumor-infiltrating T-Cells and NK Cells of Patients with Colorectal Carcinoma

    Hiroshi Nakagomi;Max Petersson;Inger Magnusson;Claes Juhlin

  • INTERFERON THERAPY IN MYELOMATOSIS

    H Mellstedt;M Björkholm;B Johansson;A Ahre

  • The challenge of biosimilars.

    Hakan Mellstedt;D. Niederwieser;H. Ludwig

  • CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

    J Lundin;Anders Osterborg;G Brittinger;Derek Crowther

  • Humanized CD52 monoclonal antibody Campath-1H as first-line treatment in chronic lymphocytic leukaemia.

    Anders ÖSterborg;Athanasios S. Fassas;Achilles Anagnostopoulos;Martin J. S. Dyer

  • Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.

    Masanori Matsuda;Max Petersson;Rodica Lenkei;Jean-Luc Taupin

  • A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease

    Davide Bagnara;Matthew S. Kaufman;Matthew S. Kaufman;Matthew S. Kaufman;Carlo Calissano;Sonia Marsilio

  • Idiotype Immunization Combined With Granulocyte-Macrophage Colony-Stimulating Factor in Myeloma Patients Induced Type I, Major Histocompatibility Complex–Restricted, CD8- and CD4-Specific T-Cell Responses

    Anders Österborg;Qing Yi;Lotta Henriksson;Jan Fagerberg

  • Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.

    Geoff Hale;Peppy Rebello;Lee R. Brettman;Chris Fegan

  • Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells.

    David J. McConkey;Miguel Aguilar-Santelises;Pia Hartzell;Ina Eriksson

  • A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes

    Staffan Paulie;Barbro Ehlin-Henriksson;Håkan Mellstedt;Hannu Koho

  • Inversion of chromosome 14 marks human T-cell chronic lymphocytic leukaemia

    L. Zech;G. Gahrton;L. Hammarström;G. Juliusson

  • Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.

    Amir H. DaneshManesh;Eva Mikaelsson;Mahmood Jeddi‐Tehrani;Ali Ahmad Bayat

  • Monoclonal lymphocyte population in human plasma cell myeloma.

    H. Mellstedt;S. Hammarström;G. Holm

  • Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia

    D. Killander;A. Dohlwitz;L. Engstedt;S. Franzén

  • Bcl-2, bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression

    Miguel Aguilar-Santelises;Martín E. Rottenberg;Nongnit Lewin;Håkan Mellstedt

Frequent Co-Authors

Anders Österborg
Anders Österborg Karolinska Institute
Magnus Björkholm
Magnus Björkholm Karolinska University Hospital
Mahmood Jeddi-Tehrani
Mahmood Jeddi-Tehrani Avicenna Research Institute
Bo Nilsson
Bo Nilsson Uppsala University
Peter Biberfeld
Peter Biberfeld Karolinska Institute
Mikael Jondal
Mikael Jondal Karolinska Institute
Giuseppe Masucci
Giuseppe Masucci Karolinska Institute
Britta Wahren
Britta Wahren Karolinska Institute
Rolf Kiessling
Rolf Kiessling Karolinska Institute
George Klein
George Klein Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open numerous career doors. Many students pursue accelerated paths such as ABSN programs, and finding absn programs with high acceptance rates can help simplify the admission process while advancing quickly toward nursing roles.

Similarly, those considering foundational nursing careers might explore LPN options. Programs highlighted in lpn programs with easiest admission requirements offer accessible entry points for students aiming to begin clinical work in healthcare settings without prohibitive entry barriers.

For advanced practice, nurse practitioner degrees are highly relevant. Identifying which nurse practitioner program is easiest can be crucial for students seeking programs that balance rigorous curriculum with flexible admission policies and efficient completion timelines.

Additionally, those passionate about mental health can specialize through programs such as the best psychiatric mental health nurse practitioner programs online. These options combine strong clinical placements with convenient online formats, preparing graduates for vital roles in psychiatric care.

Best Scientists Citing Håkan Mellstedt

Trending Scientists

Recently Published Articles